Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / CL A
-
Number of holders
-
119
-
Total 13F shares, excl. options
-
15,714,340
-
Shares change
-
+3,500,427
-
Total reported value, excl. options
-
$1,284,826,970
-
Value change
-
+$296,295,233
-
Put/Call ratio
-
70%
-
Number of buys
-
78
-
Number of sells
-
-35
-
Price
-
$81.76
Significant Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q3 2018
134 filings reported holding RETA - REATA PHARMACEUTICALS INC - CL A as of Q3 2018.
REATA PHARMACEUTICALS INC - CL A (RETA) has 119 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15,714,340 shares
.
Largest 10 shareholders include CPMG Inc (2,912,523 shares), BlackRock Inc. (1,928,362 shares), Vanguard Group Inc (1,187,632 shares), FRANKLIN RESOURCES INC (859,013 shares), Point72 Asset Management, L.P. (749,800 shares), FARALLON CAPITAL MANAGEMENT LLC (673,500 shares), Cormorant Asset Management, LP (660,000 shares), EMERALD ADVISERS INC/PA (473,275 shares), EMERALD MUTUAL FUND ADVISERS TRUST (444,492 shares), and STATE STREET CORP (407,102 shares).
This table shows the top 119 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.